LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 74.22 | 84.90 | 732 | 9343 | 0.0783 | 0.3739 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 74.22 | 84.90 | 9864 | 9343 | 1.0557 | 1.0161 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 75.93 | 84.90 | 406 | 8970 | 0.0453 | 0.2621 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 75.93 | 84.90 | 7723 | 8970 | 0.8609 | 0.9559 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 75.93 | 84.90 | 710 | 8970 | 0.0791 | 0.3715 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 75.93 | 84.90 | 10071 | 8970 | 1.1227 | 1.0347 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 77.64 | 84.90 | 453 | 9245 | 0.0490 | 0.2808 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 77.64 | 84.90 | 7880 | 9245 | 0.8523 | 0.9533 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 77.64 | 84.90 | 796 | 9245 | 0.0861 | 0.3920 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 77.64 | 84.90 | 10266 | 9245 | 1.1104 | 1.0312 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 79.34 | 84.90 | 465 | 9051 | 0.0514 | 0.2872 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 79.34 | 84.90 | 8015 | 9051 | 0.8855 | 0.9642 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 79.34 | 84.90 | 774 | 9051 | 0.0855 | 0.3883 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 79.34 | 84.90 | 10465 | 9051 | 1.1562 | 1.0435 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 81.05 | 84.90 | 409 | 8863 | 0.0461 | 0.2642 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 81.05 | 84.90 | 8138 | 8863 | 0.9181 | 0.9747 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 81.05 | 84.90 | 711 | 8863 | 0.0802 | 0.3729 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 81.05 | 84.90 | 10657 | 8863 | 1.2023 | 1.0557 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.75 | 84.90 | 415 | 8621 | 0.0481 | 0.2688 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.75 | 84.90 | 8304 | 8621 | 0.9632 | 0.9888 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.75 | 84.90 | 715 | 8621 | 0.0829 | 0.3767 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.75 | 84.90 | 10880 | 8621 | 1.2620 | 1.0710 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.45 | 84.90 | 331 | 8254 | 0.0401 | 0.2288 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.45 | 84.90 | 8445 | 8254 | 1.0230 | 1.0069 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.45 | 84.90 | 719 | 8254 | 0.0871 | 0.3820 | MN20160318_Q02 | I17 |